486 related articles for article (PubMed ID: 29198569)
1. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
[TBL] [Abstract][Full Text] [Related]
3. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer screening with the fecal immunochemical test in persons aged 30 to 49 years: focusing on the age for commencing screening.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
Gastrointest Endosc; 2017 Nov; 86(5):892-899. PubMed ID: 28385585
[TBL] [Abstract][Full Text] [Related]
5. Fecal hemoglobin concentration is useful for risk stratification of advanced colorectal neoplasia.
Kim NH; Kwon MJ; Kim HY; Lee T; Jeong SH; Park DI; Choi K; Jung YS
Dig Liver Dis; 2016 Jun; 48(6):667-72. PubMed ID: 27012445
[TBL] [Abstract][Full Text] [Related]
6. Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.
Kim NH; Lim JW; Kim S; Lim JY; Kim W; Park JH; Park DI; Sohn CI; Jung YS
Dig Liver Dis; 2019 Apr; 51(4):589-594. PubMed ID: 30733186
[TBL] [Abstract][Full Text] [Related]
7. Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer.
Park CH; Kim NH; Park JH; Park DI; Sohn CI; Jung YS
Gastrointest Endosc; 2018 Jul; 88(1):128-135. PubMed ID: 29510145
[TBL] [Abstract][Full Text] [Related]
8. A quantitative immunochemical fecal occult blood test for colorectal neoplasia.
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Leshno M; Niv Y
Ann Intern Med; 2007 Feb; 146(4):244-55. PubMed ID: 17310048
[TBL] [Abstract][Full Text] [Related]
9. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
[No Abstract] [Full Text] [Related]
11. Findings from the first colorectal cancer screening among 103 542 individuals in Vietnam with systematic review of colorectal cancer screening programs in Asia-Pacific region.
Tran CT; Nguyen MV; Tran MT; Tuong TT; Tran QH; Le LC; Pham HT; Bui NC; Vu HH; Nguyen TT; Ta PQ; Ha HT; Trinh DT; Bui HT; Trinh DQ; Van Nguyen K; Le SH; Van Vu K; Van Tran T; Tran HT; Shrubsole MJ; Ye F; Cai Q; Zheng W; Boffetta P; Shu XO; Luu HN
Jpn J Clin Oncol; 2022 Jul; 52(7):707-715. PubMed ID: 35383373
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary application of the Asia-Pacific colorectal screening score combined with the quantitative fecal occult blood in colorectal neoplasia screening].
Kang Q; Li N; Wang RF; Yang L; Jin P; Sheng JQ
Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3825-3828. PubMed ID: 34895425
[TBL] [Abstract][Full Text] [Related]
13. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
Chiu HM; Ching JY; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Sung JJ;
Gastroenterology; 2016 Mar; 150(3):617-625.e3. PubMed ID: 26627608
[TBL] [Abstract][Full Text] [Related]
14. The fecal immunochemical test has high accuracy for detecting advanced colorectal neoplasia before age 50.
Kim NH; Park JH; Park DI; Sohn CI; Choi K; Jung YS
Dig Liver Dis; 2017 May; 49(5):557-561. PubMed ID: 28065631
[TBL] [Abstract][Full Text] [Related]
15. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
[TBL] [Abstract][Full Text] [Related]
16. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.
Yeoh KG; Ho KY; Chiu HM; Zhu F; Ching JY; Wu DC; Matsuda T; Byeon JS; Lee SK; Goh KL; Sollano J; Rerknimitr R; Leong R; Tsoi K; Lin JT; Sung JJ;
Gut; 2011 Sep; 60(9):1236-41. PubMed ID: 21402615
[TBL] [Abstract][Full Text] [Related]
17. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea.
Kim DH; Cha JM; Shin HP; Joo KR; Lee JI; Park DI
J Clin Gastroenterol; 2015 Jan; 49(1):41-9. PubMed ID: 24583751
[TBL] [Abstract][Full Text] [Related]
19. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
20. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
